286 related articles for article (PubMed ID: 21050481)
1. HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression.
Kessler J; Hahnel A; Wichmann H; Rot S; Kappler M; Bache M; Vordermark D
BMC Cancer; 2010 Nov; 10():605. PubMed ID: 21050481
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hypoxia-inducible factor-1 alpha radiosensitized MG-63 human osteosarcoma cells in vitro.
Jin Z; Aixi Y; Baiwen Q; Zonghuan L; Xiang H
Tumori; 2015; 101(5):578-84. PubMed ID: 26350185
[TBL] [Abstract][Full Text] [Related]
3. Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells.
Staab A; Loeffler J; Said HM; Diehlmann D; Katzer A; Beyer M; Fleischer M; Schwab F; Baier K; Einsele H; Flentje M; Vordermark D
BMC Cancer; 2007 Nov; 7():213. PubMed ID: 17999771
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
[TBL] [Abstract][Full Text] [Related]
6. Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.
Fernandez EV; Reece KM; Ley AM; Troutman SM; Sissung TM; Price DK; Chau CH; Figg WD
Mol Pharmacol; 2015 Jun; 87(6):1006-12. PubMed ID: 25829060
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.
Said HM; Staab A; Hagemann C; Vince GH; Katzer A; Flentje M; Vordermark D
J Neurooncol; 2007 Jan; 81(1):27-38. PubMed ID: 16944313
[TBL] [Abstract][Full Text] [Related]
8. Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro.
Staab A; Fleischer M; Loeffler J; Said HM; Katzer A; Plathow C; Einsele H; Flentje M; Vordermark D
Strahlenther Onkol; 2011 Apr; 187(4):252-9. PubMed ID: 21437769
[TBL] [Abstract][Full Text] [Related]
9. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
11. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer.
Said HM; Supuran CT; Hageman C; Staab A; Polat B; Katzer A; Scozzafava A; Anacker J; Flentje M; Vordermark D
Curr Pharm Des; 2010; 16(29):3288-99. PubMed ID: 20819065
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
Dungwa JV; Hunt LP; Ramani P
BMC Cancer; 2011 Sep; 11():390. PubMed ID: 21910893
[TBL] [Abstract][Full Text] [Related]
13. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1alpha blocks differentiation of malignant gliomas.
Lu H; Li Y; Shu M; Tang J; Huang Y; Zhou Y; Liang Y; Yan G
FEBS J; 2009 Dec; 276(24):7291-304. PubMed ID: 19912340
[TBL] [Abstract][Full Text] [Related]
15. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
16. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
[TBL] [Abstract][Full Text] [Related]
17. Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions.
Bache M; Zschornak MP; Passin S; Kessler J; Wichmann H; Kappler M; Paschke R; Kaluđerović GN; Kommera H; Taubert H; Vordermark D
Radiat Oncol; 2011 Sep; 6():111. PubMed ID: 21906280
[TBL] [Abstract][Full Text] [Related]
18. Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma.
Viziteu E; Grandmougin C; Goldschmidt H; Seckinger A; Hose D; Klein B; Moreaux J
Br J Cancer; 2016 Mar; 114(5):519-23. PubMed ID: 26867162
[TBL] [Abstract][Full Text] [Related]
19. Kinome siRNA screen identifies SMG-1 as a negative regulator of hypoxia-inducible factor-1alpha in hypoxia.
Chen RQ; Yang QK; Chen YL; Oliveira VA; Dalton WS; Fearns C; Lee JD
J Biol Chem; 2009 Jun; 284(25):16752-16758. PubMed ID: 19406746
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas.
Jensen RL; Ragel BT; Whang K; Gillespie D
J Neurooncol; 2006 Jul; 78(3):233-47. PubMed ID: 16612574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
